Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/9410
Posicionamiento del Comité Español Interdisciplinario de Prevención Cardiovascular y la Sociedad Española de Cardiología en el tratamiento de las dislipemias. Divergencia entre las guías europea y estadounidense
Lobos Bejarano, José María | Galve, Enrique | Royo-Bordonada, Miguel Angel ISCIII | Alegría Ezquerra, Eduardo | Armario, Pedro | Brotons Cuixart, Carlos | Camafort Babkowski, Miguel | Cordero Fort, Alberto | Maiques Galán, Antonio | Mantilla Morató, Teresa | Pérez Pérez, Antonio | Pedro-Botet, Juan | Villar Alvarez, Fernando ISCIII | Gonzalez-Juanatey, Jose R
Rev Esp Cardiol (Engl Ed). 2014 Nov;67(11):913-9.
The publication of the 2013 American College of Cardiology/American Heart Association guidelines on the treatment of high blood cholesterol has had a strong impact due to the paradigm shift in its recommendations. The Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology reviewed this guideline and compared it with current European guidelines on cardiovascular prevention and dyslipidemia management. The most striking aspect of the American guideline is the elimination of the low-density lipoprotein cholesterol treat-to-target strategy and the adoption of a risk reduction strategy in 4 major statin benefit groups. In patients with established cardiovascular disease, both guidelines recommend a similar therapeutic strategy (high-dose potent statins). However, in primary prevention, the application of the American guidelines would substantially increase the number of persons, particularly older people, receiving statin therapy. The elimination of the cholesterol treat-to-target strategy, so strongly rooted in the scientific community, could have a negative impact on clinical practice, create a certain amount of confusion and uncertainty among professionals, and decrease follow-up and patient adherence. Thus, this article reaffirms the recommendations of the European guidelines. Although both guidelines have positive aspects, doubt remains regarding the concerns outlined above. In addition to using risk charts based on the native population, the messages of the European guideline are more appropriate to the Spanish setting and avoid the possible risk of overtreatment with statins in primary prevention.
Cardiovascular prevention | Clinical guidelines | Dislipemias | Dyslipidemia | Guías clínicas | Prevención cardiovascular
Adult | Aged | Cardiology | Cardiovascular Diseases | Dyslipidemias | Female | Humans | Hypolipidemic Agents | Male | Middle Aged | Societies, Medical | Spain | Practice Guidelines as Topic
Files in this item
- PosicionamientoDelComitéEspan ...